TB

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.

This course was designed to give hands-on practice in identifying when and how an Isoniazid Preventive Therapy (IPT) program can be used in the prevention of tuberculosis in people living with HIV. Depending on individual pace and previous knowledge, this course requires around 30 to 45 minutes to complete.

This pocket-sized card for clinicians provides information on identifying those at risk for TB. The resource also includes content on latent TB infection testing, diagnosis, and treatment in adults. 

This guide is designed to explain the safety and efficacy of bedaquiline. It also describes what you as an activist can do to help ensure access, fair pricing and further research. The guide provides messages that regulatory authorities need to hear to prepare for bedaquiline and other new TB drugs.

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing.

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. 

In this video, Dr. Caralee Caplan-Shaw and her patients clarify the risks of untreated latent TB infection and motivate your patients to complete treatment.

The main purpose of this guide is to describe and explain how to design, implement and analyse an inventory study to measure TB under-reporting. The guide also explains how to apply capture-recapture methods to estimate TB incidence, emphasizing the conditions that must be fulfilled for these methods to be used. This guide is intended for use by NTP managers, researchers including epidemiologists and statisticians, and agencies that provide financial and technical support for inventory studies.

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This fact sheet provides information regarding TB/HIV coinfection worldwide. It also presents key activities being conducted by the WHO in response to TB/HIV coinfection.